PuSH - Publikationsserver des Helmholtz Zentrums München

Lorenz, F.K.* ; Ellinger, C. ; Kieback, E.* ; Wilde, S. ; Lietz, M.* ; Schendel, D.J. ; Uckert, W.*

Unbiased identification of T-cell receptors Targeting immunodominant peptide-MHC complexes for T-cell receptor immunotherapy.

Hum. Gene Ther. 28, 1158-1168 (2017)
DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
T-cell receptor (TCR) immunotherapy uses T cells engineered with new TCRs to enable detection and killing of cancer cells. Efficacy of TCR immunotherapy depends on targeting antigenic peptides that are efficiently presented by the best-suited major histocompatibility complex (MHC) molecules of cancer cells. However, efficient strategies are lacking to easily identify TCRs recognizing immunodominant peptide-MHC (pMHC) combinations utilizing any of the six possible MHC class I alleles of a cancer cell. We generated an MHC cell library and developed a platform approach to detect, isolate, and re-express TCRs specific for immunodominant pMHCs. The platform approach was applied to identify a human papillomavirus (HPV16) oncogene E5-specific TCR, recognizing a novel, naturally processed pMHC (HLA-B*15:01) and a cytomegalovirus-specific TCR targeting an immunodominant pMHC (HLA-B*07:02). The platform provides a useful tool to isolate in an unbiased manner TCRs specific for novel and immunodominant pMHC targets for use in TCR immunotherapy.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Immunotherapy ; T Cell Receptor (tcr) Discovery ; Tcr Gene Therapy ; Mhc Cell Library ; Immunodominance ; Human Papillamavirus Es; Antigen-presenting Cells; Gamma Elispot Assays; Tcr Gene-therapy; Dendritic Cells; Retroviral Vectors; Antitumor-activity; E5 Oncoprotein; Lymphocytes; Expression; Cancer
ISSN (print) / ISBN 1043-0342
e-ISSN 1557-7422
Zeitschrift Human Gene Therapy. Clinical Development
Quellenangaben Band: 28, Heft: 12, Seiten: 1158-1168 Artikelnummer: , Supplement: ,
Verlag Mary Ann Liebert
Verlagsort New Rochelle
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) AG Translationale Molekulare Immunologie (TMI)